183 related articles for article (PubMed ID: 37331977)
1. RNA aptamers with specific binding affinity to CD40 (CD40Apt) represents a promising antagonist of the CD40-CD40L signaling for thyroid-associated ophthalmopathy (TAO) treatment in mouse.
Chen Y; Tang R; Xiong W; Zhang F; Wang N; Xie B; Cao J; Chen Z; Ma C
J Transl Med; 2023 Jun; 21(1):396. PubMed ID: 37331977
[TBL] [Abstract][Full Text] [Related]
2. PD-L1 Inhibits T Cell-Induced Cytokines and Hyaluronan Expression
Liu Z; Liu Y; Liu M; Gong Q; Shi A; Li X; Bai X; Guan X; Hao B; Liu F; Zhou X; Yuan H
Front Immunol; 2022; 13():849480. PubMed ID: 35619700
[TBL] [Abstract][Full Text] [Related]
3. The expression of intercellular adhesion molecule-1 induced by CD40-CD40L ligand signaling in orbital fibroblasts in patients with Graves' ophthalmopathy.
Zhao LQ; Wei RL; Cheng JW; Cai JP; Li Y
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4652-60. PubMed ID: 20107176
[TBL] [Abstract][Full Text] [Related]
4. IL-17A Promotes RANTES Expression, But Not IL-16, in Orbital Fibroblasts Via CD40-CD40L Combination in Thyroid-Associated Ophthalmopathy.
Fang S; Huang Y; Zhong S; Zhang Y; Liu X; Wang Y; Gu P; Zhou H; Fan X
Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6123-6133. PubMed ID: 27832278
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κB.
Gillespie EF; Raychaudhuri N; Papageorgiou KI; Atkins SJ; Lu Y; Charara LK; Mester T; Smith TJ; Douglas RS
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7746-53. PubMed ID: 23092922
[TBL] [Abstract][Full Text] [Related]
6. Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1.
Hwang CJ; Afifiyan N; Sand D; Naik V; Said J; Pollock SJ; Chen B; Phipps RP; Goldberg RA; Smith TJ; Douglas RS
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2262-8. PubMed ID: 19117935
[TBL] [Abstract][Full Text] [Related]
7. Botox-A improve the thyroid-associated ophthalmopathy (TAO) orbital fibroblast activation through inhibiting the TGF-β/Smad signaling.
Qi X; Luo B; Deng M; Cao J; Hou S; Xie Z; Tong B; Xiong W
Exp Eye Res; 2022 Apr; 217():108971. PubMed ID: 35108585
[TBL] [Abstract][Full Text] [Related]
8. Octreotide inhibits secretion of IGF-1 from orbital fibroblasts in patients with thyroid-associated ophthalmopathy via inhibition of the NF-κB pathway.
Kim SE; Kim J; Lee JY; Lee SB; Paik JS; Yang SW
PLoS One; 2021; 16(4):e0249988. PubMed ID: 33886620
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid induces COX-2 expression via CD44 in orbital fibroblasts from patients with thyroid-associated ophthalmopathy.
Lim HS; Back KO; Kim HJ; Choi YH; Park YM; Kook KH
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7441-50. PubMed ID: 25342622
[TBL] [Abstract][Full Text] [Related]
10. MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy.
Tong BD; Xiao MY; Zeng JX; Xiong W
Mol Vis; 2015; 21():324-34. PubMed ID: 25873777
[TBL] [Abstract][Full Text] [Related]
11. Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production.
Sempowski GD; Rozenblit J; Smith TJ; Phipps RP
Am J Physiol; 1998 Mar; 274(3):C707-14. PubMed ID: 9530102
[TBL] [Abstract][Full Text] [Related]
12. The miR-103a-3p/TGFBR3 axis regulates TGF-β-induced orbital fibroblast activation and fibrosis in thyroid-eye disease.
Xie B; Xiong W; Zhang F; Wang N; Luo Y; Chen Y; Cao J; Chen Z; Ma C; Chen H
Mol Cell Endocrinol; 2023 Jan; 559():111780. PubMed ID: 36179941
[TBL] [Abstract][Full Text] [Related]
13. Antifibrotic effect of Pirfenidone on orbital fibroblasts of patients with thyroid-associated ophthalmopathy by decreasing TIMP-1 and collagen levels.
Kim H; Choi YH; Park SJ; Lee SY; Kim SJ; Jou I; Kook KH
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3061-6. PubMed ID: 20053983
[TBL] [Abstract][Full Text] [Related]
14. Palmitate induced secretion of IL-6 and MCP-1 in orbital fibroblasts derived from patients with thyroid-associated ophthalmopathy.
Paik JS; Cho WK; Oh EH; Lee SB; Yang SW
Mol Vis; 2012; 18():1467-77. PubMed ID: 22736938
[TBL] [Abstract][Full Text] [Related]
15. IL-11 Is Elevated and Drives the Profibrotic Phenotype Transition of Orbital Fibroblasts in Thyroid-Associated Ophthalmopathy.
Wu P; Lin B; Huang S; Meng J; Zhang F; Zhou M; Hei X; Ke Y; Yang H; Huang D
Front Endocrinol (Lausanne); 2022; 13():846106. PubMed ID: 35273577
[TBL] [Abstract][Full Text] [Related]
16. Clinical Management and Therapeutic Strategies for the Thyroid-Associated Ophthalmopathy: Current and Future Perspectives.
Mishra S; Maurya VK; Kumar S; Ankita ; Kaur A; Saxena SK
Curr Eye Res; 2020 Nov; 45(11):1325-1341. PubMed ID: 32567373
[TBL] [Abstract][Full Text] [Related]
17. Effect of Prunella vulgaris polysaccharides on cultured orbit fibroblasts in vitro from patients with thyroid-associated ophthalmopathy.
Li B; Guo J; Wang F; Cheng S; Zeng L
Exp Eye Res; 2020 Dec; 201():108276. PubMed ID: 32991886
[TBL] [Abstract][Full Text] [Related]
18. Lutein targeting orbital fibroblasts attenuates fibrotic and inflammatory effects in thyroid-associated ophthalmopathy.
Hei X; Lin B; Wu P; Li X; Mao Z; Huang S; Zhang F; Zhou M; Ke Y; Yang H; Huang D
Exp Eye Res; 2023 Jul; 232():109515. PubMed ID: 37207866
[TBL] [Abstract][Full Text] [Related]
19. Pirfenidone attenuates IL-1β-induced COX-2 and PGE2 production in orbital fibroblasts through suppression of NF-κB activity.
Choi YH; Back KO; Kim HJ; Lee SY; Kook KH
Exp Eye Res; 2013 Aug; 113():1-8. PubMed ID: 23664858
[TBL] [Abstract][Full Text] [Related]
20. CD40 ligand induces expression of vascular cell adhesion molecule 1 and E-selectin in orbital fibroblasts from patients with Graves' orbitopathy.
Wang H; Zhu LS; Cheng JW; Cai JP; Li Y; Ma XY; Wei RL
Graefes Arch Clin Exp Ophthalmol; 2015 Apr; 253(4):573-82. PubMed ID: 25576172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
